FTUS
ABBV icon

Flow Traders U.S.’s AbbVie ABBV Stock Holding History

Flow Traders U.S.’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
1,352
-2,787
-67% -$600K 0.01% 743
2026
Q1 		$900K Buy
+4,139
New +$918K 0.03% 487
2025
Q1 		– Sell
-5,133
Closed -$912K – 895
2024
Q4 		$912K Buy
+5,133
New +$944K 0.04% 417

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Flow Traders U.S.'s ABBV Position: Q2 2026 in Review

Flow Traders U.S. reduced its AbbVie (ABBV) stake by 67% in Q2 2026, selling an estimated $600K and leaving 1,352 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #743.

Flow Traders U.S. first reported a position in ABBV in Q4 2024 and has held it in 3 quarters since. The position peaked at $912K in Q4 2024. 4,231 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Flow Traders U.S. held 1,352 shares of AbbVie worth $340K as of Q2 2026.
  • Flow Traders U.S. sold 2,787 AbbVie shares in Q2 2026, an estimated $600K.
  • AbbVie made up 0.01% of Flow Traders U.S.'s portfolio in Q2 2026, its #743 holding.
  • Flow Traders U.S. first reported a position in AbbVie in Q4 2024 and has held it in 3 quarters since.
  • Flow Traders U.S.'s AbbVie position peaked at $912K in Q4 2024.
  • 4,231 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.